Cheng, Wen-Fang <br/><br/>
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Nov 2005 
 - 960-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0016 
<br/><br/><label>Standard No.: </label>10.1016/j.ymthe.2005.04.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines<br/>Cell Line, Tumor<br/>Down-Regulation<br/>Fas Ligand Protein<br/>Female<br/>Genetic Therapy<br/>Histocompatibility Antigens Class I<br/>Interferon-gamma--metabolism<br/>Membrane Glycoproteins--biosynthesis<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasms, Experimental--metabolism<br/>T-Lymphocytes, Cytotoxic--metabolism<br/>Tumor Necrosis Factors--biosynthesis<br/>Vaccines, DNA<br/>fas Receptor--metabolism